Showing results (71-80 of 143) with videos related to
Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2019
High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in MelanomaKenneth H Buetow, Lydia R Meador, Hari Menon, et al.Journal of Clinical Medicine|February 25, 2022
Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced ArthralgiasJessica A Martinez, Mihra S Taljanovic, Andres A Nuncio Zuniga, et al.Journal of Primary Care & Community Health|December 6, 2021
Feasibility and Acceptability of a Type 2 Diabetes Prevention Intervention for Mothers and Children at a Federally Qualified Healthcare CenterMelanie Hingle, Robert Blew, Kyla James, et al.Plos One|April 27, 2018
Celecoxib use and circulating oxylipins in a colon polyp prevention trialJessica A Martinez, Jun Yang, Betsy C Wertheim, et al.Bone|December 21, 2018
Relationship of cardiometabolic risk biomarkers with DXA and pQCT bone health outcomes in young girlsMegan Hetherington-Rauth, Jennifer W Bea, Robert M Blew, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trialDenise H Frank, Denise J Roe, H-H Sherry Chow, et al.Biomarker Research|December 2, 2022
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancerPaweł Łaniewski, Haiyan Cui, Nichole D Mahnert, et al.Scientific Reports|May 16, 2019
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesisPaweł Łaniewski, Haiyan Cui, Denise J Roe, et al.Annals of Surgical Oncology|June 8, 2002
Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patientsHarris Bernstein, Hana Holubec, James A Warneke, et al.Investigational New Drugs|May 15, 2012
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancerAmanda F Baker, Denise J Roe, Cynthia Laughren, et al.Pageof 15